2XMY PDB NFT

Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeifa4kotpetezcgb37g2dg22dxps5njbpfjwejuxarou6lffd3lyoq/metadata.json

IPFS of structure file:

bafybeig7cfl5kljehtpfrnnok5gz2xmiqirjr2nrzrd4mzcti2o222jywq/2xmy.pdb

MOLNFT 2XMY research and analysis (ICN3D with VR)

FASTA sequences

>2xmy_A mol:protein length:298 CELL DIVISION PROTEIN KINASE 2
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 2XMY
TITLE: Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents
DOI: 10.1016/j.chembiol.2010.07.016
AUTHORS: Wang, S., Griffiths, G., Midgley, C.A., Barnett, A.L., Cooper, M., Grabarek, J., Ingram, L., Jackson, W., Kontopidis, G., McClue, S.J., McInnes, C., McLachlan, J., Meades, C., Mezna, M., Stuart, I., Thomas, M.P., Zheleva, D.I., Lane, D.P., Jackson, R.C., Glover, D.M., Blake, D.G., Fischer, P.M.
ACCESSION DATE: 07/29/10
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/2XMY